Viewing Study NCT05815303


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-06-15 @ 10:20 AM
Study NCT ID: NCT05815303
Status: RECRUITING
Last Update Posted: 2023-04-18
First Post: 2023-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Cancer View
None MSS View
Keywords: